Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Syrian Loses Job Due to Cross Necklace

A Syrian employee was fired after being asked to take off…
Read more

China Coast Guard to Use Force

Xi Jinping of China has put a new law in place that authorizes…
Read more

Approval for More Construction on U.S. Embassy

Plans were recently approved to begin an expansion of the…
Read more